LabPulse.com
  • Business Insights
  • Diagnostic Technologies
  • Diseases
  • Point-of-Care Testing
  • Research & Development
  • Sign In
  • Autoimmune
  • Cancer
  • Cardiovascular
  • COVID-19
  • Health Topics
  • Infectious
Stay in the Know
Stay in the Know
Delivered right to your inbox, LabPulse’s newsletters keep you informed on the latest clinical lab updates. Subscribe to get exclusive access!
Business Insights
  • Policy & Regulation
  • Trends & Finance
Research & Development
  • Clinical Trials
  • Collaboration
  • Funding
Diagnostic Technologies
  • Clinical Chemistry
  • Emerging Technology
  • Immunoassays
  • Molecular Diagnostics
  • Pathology & AI
Diseases
  • Autoimmune
  • Cancer
  • Cardiovascular
  • COVID-19
  • Health Topics
  • Infectious
Resources
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
User Tools
  • Sign In
Follow LabPulse.com
Facebook iconTwitter iconLinkedIn icon
  • Business Insights
    • Policy & Regulation
    • Trends & Finance
  • Diagnostic Technologies
    • Clinical Chemistry
    • Emerging Technology
    • Immunoassays
    • Molecular Diagnostics
    • Pathology & AI
  • Diseases
    • Autoimmune
    • Cancer
    • Cardiovascular
    • COVID-19
    • Health Topics
    • Infectious
  • Point-of-Care Testing
  • Research & Development
    • Clinical Trials
    • Collaboration
    • Funding
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
  • Sign In
Follow LabPulse.com
Facebook iconTwitter iconLinkedIn icon

Long QT Syndrome

In study, genetic testing catches missed cardiac diagnoses
Researchers at Northwestern University and colleagues reported that in their cohort study of 4,782 patients with a suspected genetic cardiomyopathy or arrhythmia, the combined testing approach captured nearly 11% of patients whose diagnosis would have been missed if genetic testing had been limited to a specific suspected disease.
August 24, 2022
2022 08 25 13 55 6515 Heart Health Stethoscope 400
Most Popular
Quest launches long-COVID testing panels for consumers
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
FDA grants 510(k) clearance to DiaSorin for COVID-19 and flu A/B assay
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Page 1 of 1
LabPulse.com
Stay Connected
Delivered right to your inbox, LabPulse’s newsletters keep you informed on the latest clinical lab updates. Subscribe to get exclusive access!
Sign Up
Topics
  • Business Insights
  • Diagnostic Technologies
  • Diseases
  • Point-of-Care Testing
  • Research & Development
Resources
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
Follow LabPulse.com
Facebook iconTwitter iconLinkedIn icon
  1. Privacy Policy
  2. Contact Us
  3. Site Map
© 2023 Science and Medicine Group. All rights reserved.